[
  {
    "ts": null,
    "headline": "Merck & Co., Inc. (MRK) Needs To Move On From Talking About Its Animal Division, Says Jim Cramer",
    "summary": "We recently published 13 Stocks That Jim Cramer Recently Talked About. Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently discussed. Merck & Co., Inc. (NYSE:MRK)’s shares have lost 18.3% year-to-date on the back of several factors, such as troubles in China and the expiration of its KEYTRUDA patents. Cramer’s previous […]",
    "url": "https://finnhub.io/api/news?id=7bbcc92ab64059416fa5c554db64405eb4b9e3379c80ae03957b1c04490fdd5b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754072810,
      "headline": "Merck & Co., Inc. (MRK) Needs To Move On From Talking About Its Animal Division, Says Jim Cramer",
      "id": 136183323,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We recently published 13 Stocks That Jim Cramer Recently Talked About. Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently discussed. Merck & Co., Inc. (NYSE:MRK)’s shares have lost 18.3% year-to-date on the back of several factors, such as troubles in China and the expiration of its KEYTRUDA patents. Cramer’s previous […]",
      "url": "https://finnhub.io/api/news?id=7bbcc92ab64059416fa5c554db64405eb4b9e3379c80ae03957b1c04490fdd5b"
    }
  },
  {
    "ts": null,
    "headline": "MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View",
    "summary": "MRNA tops Q2 estimates with a narrower loss and revenue beat, but the stock slips after trimming 2025 sales guidance.",
    "url": "https://finnhub.io/api/news?id=3a49c8107c123b7e307fa0aa7ceac15cabef1164d8a32652eaaac694eca1fee5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754068860,
      "headline": "MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View",
      "id": 136183324,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "MRNA tops Q2 estimates with a narrower loss and revenue beat, but the stock slips after trimming 2025 sales guidance.",
      "url": "https://finnhub.io/api/news?id=3a49c8107c123b7e307fa0aa7ceac15cabef1164d8a32652eaaac694eca1fee5"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co. Inc. stock underperforms Friday when compared to competitors despite daily gains",
    "summary": "Merck & Co. Inc. stock underperforms Friday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=b9017562133f5710ae4d2d0dcd9b93e25c596b39d1f4a66b9e25c76375762da1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754066040,
      "headline": "Merck & Co. Inc. stock underperforms Friday when compared to competitors despite daily gains",
      "id": 136209610,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck & Co. Inc. stock underperforms Friday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=b9017562133f5710ae4d2d0dcd9b93e25c596b39d1f4a66b9e25c76375762da1"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to watch next week: BP, Diageo, Disney, Uber and WPP",
    "summary": "Earnings preview of key companies reporting next week and what to look out for.",
    "url": "https://finnhub.io/api/news?id=8f6d19339cc79d3a0f38348d569e04f911548737030e6518d7b7f19b9bc82e26",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754062721,
      "headline": "Stocks to watch next week: BP, Diageo, Disney, Uber and WPP",
      "id": 136165211,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Earnings preview of key companies reporting next week and what to look out for.",
      "url": "https://finnhub.io/api/news?id=8f6d19339cc79d3a0f38348d569e04f911548737030e6518d7b7f19b9bc82e26"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market News for Aug 1, 2025",
    "summary": "Wall Street closed lower on Thursday, pulled down by health care and real estate stocks.",
    "url": "https://finnhub.io/api/news?id=2267747cd146b2a165688a5bdb3ad892f7510b4c230e9c8d0ecfb7b3e3d833e5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754055000,
      "headline": "Stock Market News for Aug 1, 2025",
      "id": 136165217,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Wall Street closed lower on Thursday, pulled down by health care and real estate stocks.",
      "url": "https://finnhub.io/api/news?id=2267747cd146b2a165688a5bdb3ad892f7510b4c230e9c8d0ecfb7b3e3d833e5"
    }
  },
  {
    "ts": null,
    "headline": "Reddit, Coinbase, Novo Nordisk - Trending Stocks",
    "summary": "A quick look at some of the mornings most active stocks ahead of the market open in the US - Social heavyweight Reddit (RDDT) saw a big leap, cryptocurrency exchange Coinbase (COIN) takes a beating and big pharma tumbles - with Novo Nordisk (NVO), Sanofi (SNY), and Merck (MRK) amongst those affected.",
    "url": "https://finnhub.io/api/news?id=571f136bd3a4e5802bef60b34ae83394527ca24fddbd3681c06e0b82ebd54fe4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754050522,
      "headline": "Reddit, Coinbase, Novo Nordisk - Trending Stocks",
      "id": 136165371,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "A quick look at some of the mornings most active stocks ahead of the market open in the US - Social heavyweight Reddit (RDDT) saw a big leap, cryptocurrency exchange Coinbase (COIN) takes a beating and big pharma tumbles - with Novo Nordisk (NVO), Sanofi (SNY), and Merck (MRK) amongst those affected.",
      "url": "https://finnhub.io/api/news?id=571f136bd3a4e5802bef60b34ae83394527ca24fddbd3681c06e0b82ebd54fe4"
    }
  },
  {
    "ts": null,
    "headline": "Testicular Cancer Market Analysis and Forecast Report 2025-2035 | Emerging Trends Highlight Shift Towards Immunotherapy in Testicular Cancer",
    "summary": "Testicular cancer, primarily affecting men aged 15-35, is witnessing advancements that significantly impact diagnosis and treatment outcomes. As the most common cancer in young men, early detection, primarily via ultrasound and blood tests, is critical, boasting over a 95% survival rate in localized cases. The market is growing due to heightened awareness, novel therapies, and personalization in treatment approaches by leading companies like Pfizer, Merck, and Roche. Challenges include high trea",
    "url": "https://finnhub.io/api/news?id=6a2ae63fc85eda204704834e50188b4d089145d42820650384a199a85c7f3c53",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754038260,
      "headline": "Testicular Cancer Market Analysis and Forecast Report 2025-2035 | Emerging Trends Highlight Shift Towards Immunotherapy in Testicular Cancer",
      "id": 136165372,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Testicular cancer, primarily affecting men aged 15-35, is witnessing advancements that significantly impact diagnosis and treatment outcomes. As the most common cancer in young men, early detection, primarily via ultrasound and blood tests, is critical, boasting over a 95% survival rate in localized cases. The market is growing due to heightened awareness, novel therapies, and personalization in treatment approaches by leading companies like Pfizer, Merck, and Roche. Challenges include high trea",
      "url": "https://finnhub.io/api/news?id=6a2ae63fc85eda204704834e50188b4d089145d42820650384a199a85c7f3c53"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co. assembles an Alzheimer’s comeback with a next-gen precision focus",
    "summary": "With two molecules in mid-stage trials, the pharma giant is taking another swing at the difficult disease with a greater understanding of its drivers.",
    "url": "https://finnhub.io/api/news?id=25dd9c096cf792ce59ec238cbdaeeeb67cc7cdb50ac4be25ccd60fd34d09568b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754035200,
      "headline": "Merck & Co. assembles an Alzheimer’s comeback with a next-gen precision focus",
      "id": 136165221,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "With two molecules in mid-stage trials, the pharma giant is taking another swing at the difficult disease with a greater understanding of its drivers.",
      "url": "https://finnhub.io/api/news?id=25dd9c096cf792ce59ec238cbdaeeeb67cc7cdb50ac4be25ccd60fd34d09568b"
    }
  },
  {
    "ts": null,
    "headline": "Top 10 High-Yield Dividend Stocks For August 2025",
    "summary": "Top 10 High-Yield Dividend Stocks For August 2025",
    "url": "https://finnhub.io/api/news?id=aed65d1f2356b2efa833a4ff38cfc4f816ef3ea4f1965a0a18970a1b13b5914c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754032500,
      "headline": "Top 10 High-Yield Dividend Stocks For August 2025",
      "id": 136163729,
      "image": "",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=aed65d1f2356b2efa833a4ff38cfc4f816ef3ea4f1965a0a18970a1b13b5914c"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer on Merck’s Latest Quarterly Report: “I Actually Liked It”",
    "summary": "Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently talked about. Cramer mentioned the stock and said that he liked its quarter. He remarked: “What do we make of the numbers that we got from Merck this morning? The pharma titan reported what some thought was a mixed quarter. I actually […]",
    "url": "https://finnhub.io/api/news?id=3c0f85239481d30fa96eb15bdc8a12bd392bbe7adeec0276cabe88875543d6f4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754019147,
      "headline": "Jim Cramer on Merck’s Latest Quarterly Report: “I Actually Liked It”",
      "id": 136160993,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently talked about. Cramer mentioned the stock and said that he liked its quarter. He remarked: “What do we make of the numbers that we got from Merck this morning? The pharma titan reported what some thought was a mixed quarter. I actually […]",
      "url": "https://finnhub.io/api/news?id=3c0f85239481d30fa96eb15bdc8a12bd392bbe7adeec0276cabe88875543d6f4"
    }
  }
]